Vigil Neuroscience Inc (VIGL)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: VIGL Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
2023-11-20	2023-11-20	B Purchase	Magovcevic-Liebisch Ivana President and CEO Executive Director	4,000 +2.0% 3.75 15,000 USD	4,000 +2.0%	3.75	15,000 USD
2022-11-22	2022-11-18	PS Planned sale	Papapetropoulos Spyros Chief Medical Officer Officer	300 -7.0% 14.00 4,200 USD	300 -7.0%	14.00	4,200 USD
2022-05-17	2022-05-17	B Purchase	Thorp Clay Non-Executive Director	14,893 +1.0% 2.97 44,189 USD	14,893 +1.0%	2.97	44,189 USD
2022-05-17	2022-05-16	B Purchase	Thorp Clay Non-Executive Director	21,802 +1.4% 2.76 60,221 USD	21,802 +1.4%	2.76	60,221 USD
2022-05-06	2022-05-05	B Purchase	Thackaberry Evan SVP, Head of Early Development Officer	1,500 +inf% 4.00 6,000 USD	1,500 +inf%	4.00	6,000 USD
2022-05-04	2022-05-03	B Purchase	Verni Christopher General Counsel Officer	4,000 +inf% 3.77 15,074 USD	4,000 +inf%	3.77	15,074 USD
2022-05-04	2022-05-03	B Purchase	Magovcevic-Liebisch Ivana President and CEO Executive Director	1,000 +0.5% 3.94 3,940 USD	1,000 +0.5%	3.94	3,940 USD
2022-05-04	2022-05-03	B Purchase	Ziolkowski Jennifer Lynn Chief Financial Officer Officer	4,000 +inf% 3.77 15,098 USD	4,000 +inf%	3.77	15,098 USD
2022-05-04	2022-05-03	B Purchase	Papapetropoulos Spyros Chief Medical Officer Officer	4,000 +inf% 3.40 13,591 USD	4,000 +inf%	3.40	13,591 USD
2022-05-04	2022-05-02	B Purchase	Magovcevic-Liebisch Ivana President and CEO Executive Director	4,000 +2.0% 3.61 14,439 USD	4,000 +2.0%	3.61	14,439 USD
2022-03-28	2022-03-28	B Purchase	Thorp Clay Non-Executive Director	3,000 +inf% 7.20 21,604 USD	3,000 +inf%	7.20	21,604 USD
2022-01-11	2022-01-11	B Purchase	Booth Bruce Non-Executive Director	535,000 +12.5% 14.00 7,490,000 USD	535,000 +12.5%	14.00	7,490,000 USD
2022-01-11	2022-01-11	B Purchase	Northpond Ventures GP, LLC Large shareholder	355,000 +34.5% 14.00 4,970,000 USD	355,000 +34.5%	14.00	4,970,000 USD
2022-01-11	2022-01-11	B Purchase	Vida Ventures GP III, L.L.C. Large shareholder	3,852 +50.1% 14.00 53,928 USD	3,852 +50.1%	14.00	53,928 USD
2022-01-11	2022-01-11	B Purchase	Vida Ventures GP III, L.L.C. Large shareholder	1,671,148 +50.1% 14.00 23,396,072 USD	1,671,148 +50.1%	14.00	23,396,072 USD
2022-01-11	2022-01-11	B Purchase	Vitorovic Stefan Non-Executive Director	3,852 +50.1% 14.00 53,928 USD	3,852 +50.1%	14.00	53,928 USD
2022-01-11	2022-01-11	B Purchase	Vitorovic Stefan Non-Executive Director	1,671,148 +50.1% 14.00 23,396,072 USD	1,671,148 +50.1%	14.00	23,396,072 USD
2022-01-11	2022-01-11	B Purchase	Atlas Venture Fund XII, L.P. Large shareholder	535,000 +12.5% 14.00 7,490,000 USD	535,000 +12.5%	14.00	7,490,000 USD
2022-01-11	2022-01-11	B Purchase	Thorp Clay Non-Executive Director	265,000 +21.1% 14.00 3,710,000 USD	265,000 +21.1%	14.00	3,710,000 USD